1. Anik, S., McRae, G., Nerenberg, C., Worden, A., Foreman, J., JiinYu, H., Kushinsky, S., Jones, R. and Vickery, B., 1984, Nasal absorption of nasarelin acetate, the decapeptide [D-Nal(2)6] LHRH, in resus monkeys. I., J. Pharm. Sci., 73: 684.
2. Aokif F.Y. and Crawley, J.C.W., 1976, Distribution and removal of human serum albumin — technetium 99m instilled intranasally, Br. J. Clin. Pharmacol., 3: 869.
3. Barltrop, D., 1963, Diabetes insipidus treated with synthetic lysine vasopressin, Lancet, i:27S.
4. Bond, S.W., Hardy, J.G. and Wilson C.G., 1984, Deposition and clearance of nasal sprays, Proceedings of the Second European Congress of Biopharmaceutics and Pharmacokinetics, Salamanca, Spain, 93.
5. Edwards, C.R.W., Kitau, M.J., Chard, T. and Besser G.M., 1973, Vasopressin analogue DDAVP in diabetes insipidus: Clinical and laboratory studies, Br. Med. J., 3: 375.